Erik C. Emerson - Chief Executive Officer, Director at Apimeds Pharmaceuticals US, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
APUS on NYSE
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Erik C. Emerson since 10/7/2024

Holdings reported by Erik C. Emerson for Apimeds Pharmaceuticals US, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, par value $0.01 per share 750K $1.31M $1.75 May 16, 2025 Direct
Stock option (right to buy) 347K May 16, 2025 Direct Common Stock, par value $0.01 per share

Transactions reported by Erik C. Emerson for Apimeds Pharmaceuticals US, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.